Moreover, OSU-ERb-012, an estrogen receptor-β agonist, inhibits CD4+ T cells and improves cardiac remodeling in the MI-induced HF mouse model (Rosenzweig et al., 2022). This evidence concerns the gene CD4 and myocardial infarction.